(Q52629451)
Statements
Anti-DLL4 has broad spectrum activity in pancreatic cancer dependent on targeting DLL4-Notch signaling in both tumor and vasculature cells. (English)
1 reference
Wan-Ching Yen
1 reference
Marcus M Fischer
1 reference
Mark Hynes
1 reference
Jingjiang Wu
1 reference
Edward Kim
1 reference
Lucia Beviglia
1 reference
V Pete Yeung
1 reference
Xiaomei Song
1 reference
Ann M Kapoun
1 reference
John Lewicki
1 reference
Austin Gurney
1 reference
Diane M Simeone
1 reference
Timothy Hoey
1 reference
5 September 2012
1 reference
18
1 reference
5374-5386
1 reference
19
1 reference